Orotic Acid Monohydrate

CAS No. 50887-69-9

Orotic Acid Monohydrate( 24-dioxo-1H-pyrimidine-6-carboxylic acid hydrate )

Catalog No. M19884 CAS No. 50887-69-9

Orotic acid is an intermediate product in pyrimidine metabolism.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 49 In Stock
25MG 60 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Orotic Acid Monohydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Orotic acid is an intermediate product in pyrimidine metabolism.
  • Description
    Orotic acid is an intermediate product in pyrimidine metabolism.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    24-dioxo-1H-pyrimidine-6-carboxylic acid hydrate
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    50887-69-9
  • Formula Weight
    174.11
  • Molecular Formula
    C5H6N2O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 2 mg/mL (12.81 mM);Ethanol: <1 mg/mL;Water: <1 mg/mL
  • SMILES
    O.OC(=O)c1cc(=O)[nH]c(=O)[nH]1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jung E.J. et al Proliferating effect of orotic acid through mTORC1 activation mediated by negative regulation of AMPK in SK-Hep1 hepatocellular carcinoma cells. J Toxicol Sci 2012. 37(4): p. 813-21.
molnova catalog
related products
  • p-Cresol

    p-Cresol (4-methylphenol) is a partially lipophilic moiety which strongly binds to plasma protein (close to 100%) under normal conditions. p-Cresol is metabolized through conjugation mainly sulphation and glucuronization but removal of the unconjugated p-cresol is at least in part via the urine.

  • AC-261066

    AC-261066 is a retinoic acid beta2 (beta2) receptor agonist (pEC50: 8.0).

  • Bendamustine

    Bendamustine for?the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia.